Clinical evaluation, autoantibody monitoring, and individualized treatment follow-up in conditions such as rheumatoid arthritis, lupus, Sjögren's, and autoimmune thyroid disease.
Indication
- Symmetrical swelling in multiple joints with morning stiffness (suspected rheumatoid arthritis)
- Unexplained chronic fatigue, photosensitivity, rash, and joint pain (suspected lupus)
- Dry mouth and eyes accompanied by fatigue (suspected Sjögren's syndrome)
- Patients requiring follow-up for autoimmune thyroiditis (Hashimoto's, Graves')
- Evaluation of individuals with positive autoantibodies such as ANA, anti-CCP, RF
- Patients at risk for vasculitis or connective tissue diseases
- Individuals with a family history of autoimmune disease and suspicious symptoms
Preparation
- Bringing all available laboratory results and imaging studies
- Preparing a complete list of medications, vitamins, and supplements being used
- Daily recording of symptoms such as morning stiffness, joint pain, rash, and fever
- Inquiring about family history (autoimmune disease, thyroid, rheumatologic disease)
How it's performed
- Detailed history, joint examination, and assessment of skin, mucosa, and lymph nodes
- Complete blood count, sedimentation rate, CRP, and organ function tests
- Autoantibody tests such as ANA, anti-dsDNA, anti-CCP, RF, ENA panel, and complement levels (C3, C4)
- Thyroid autoantibodies (anti-TPO, anti-Tg) and TSH evaluation
- Joint ultrasound, MRI, or required imaging based on indication
- Multidisciplinary evaluation with rheumatology and planning of targeted therapy if needed
Post-procedure
- Follow-up every 1-3 months during active disease and every 3-6 months when stable
- Regular monitoring with disease activity scores (DAS28, SLEDAI, etc.)
- Periodic blood and infection screening for patients on immunosuppressive or biologic therapy
- Keeping vaccination schedule (influenza, pneumococcus, hepatitis) up to date
- Coordinated follow-up with relevant specialties for comorbidities (heart, kidney, lung)
Risks
- Increased infection risk with immunosuppressive treatment
- Possible effects of certain medications on liver, kidney, or bone marrow
- Possible additional organ involvement (kidney, lung, nervous system) during disease flares
- Weight gain, osteoporosis, and elevated blood sugar associated with steroid use
- Risk of misinterpretation since some autoantibodies may also be positive in asymptomatic individuals
FAQ
Does a positive ANA mean I am ill?
No. Low-titer ANA positivity can also be seen in healthy individuals. Diagnosis requires evaluating clinical findings, accompanying autoantibodies, and other tests together.
Are autoimmune diseases hereditary?
Genetic predisposition plays a role, but most autoimmune diseases develop through a combination of genetic, environmental, and hormonal factors. Family history increases the risk but does not guarantee transmission.
What should autoimmune patients planning pregnancy do?
Disease activity should be low before pregnancy, and medications should be adjusted to options safe in pregnancy. This process is planned in coordination with the physician.
Do autoimmune diseases ever fully resolve?
Most autoimmune diseases have a chronic course; with appropriate treatment, long-term remission and significant improvement in quality of life can be achieved, though regular follow-up is required.
Related Information
Related Medical Services
Other services in the same specialty or with similar indications you may want to explore.
Rheumatic disease follow-up
Internal Medicine Outpatient Services
Rheumatic disease follow-up — diagnosis, treatment, and monitoring service for joint, connective tissue, and autoimmune diseases.
Febrile Illness Evaluation
Internal Medicine Outpatient Services
Evaluation of febrile illness — a systematic diagnostic process for short-term and prolonged (FUO) fever.
Thyroid disease evaluation
Internal Medicine Outpatient Services
Evaluation of thyroid gland function and structural disorders with laboratory and imaging studies.
Antinuclear antibody
Medical Biochemistry
Antinuclear antibody (ANA) test — a core screening tool for systemic autoimmune diseases.
Rheumatoid factor
Medical Biochemistry
Rheumatoid factor (RF) measurement — assessment in rheumatoid arthritis and other inflammatory joint diseases.
Diabetes Monitoring
Internal Medicine Outpatient Services
Diabetes monitoring — glycemic control, organ protection, and lifestyle management for diabetes mellitus.
General Health Check-up
Internal Medicine Outpatient Services
Check-up — systemic screening in adults for risk assessment and early diagnosis.
Liver Disease Monitoring
Internal Medicine Outpatient Services
Liver disease monitoring — comprehensive follow-up and treatment management for viral hepatitis, fatty liver, and cirrhosis.